This is a commentary in the Report on Business on the recently-announced US-China trade deal, a short-term arrangement that, in my view, is contrary to the non-discrimination (MFN) rules in the WTO Agreement. It’s a purely two-way deal that favours US businesses to the prejudice of other WTO members. US China Trade Deal Comment 23 January… Read More »
The broad and aggressive out-reach of US law has again reared up in Canada. This time it’s Buy America and the requirement that the Prince Rupert ferry upgrade must use US steel. It shows how Canada can be sideswiped by the American approach in legislating with intended global effect. In this case, a rapid Canadian… Read More »
On August 27, 2014, a NAFTA panel dismissed a claim by the Canadian pharmaceutical company, Apotex Inc., that had argued that the US government had breached the non-discrimination clauses in the Agreement by issuing an Import Alert over the company’s Canadian drug manufacturing processes. In 2008 -2009. the US Food and Drug Administration had inspected… Read More »